Seeking Alpha

iShares Nasdaq Biotechnology (IBB)

()

News & PR
Market Currents

Buzz
Twitter: IBB

Analysis - Latest Articles by most recent | most commented

Many Reasons to Launch a Global Generic Drug ETF

Dec 24 • Mike Havrilla • 5 Comments
Which ETFs Were Spurned by the Health Care Bill?

Dec 23 • Tom Lydon • Comment!
Matt Hougan: Thoughts on Choosing the Right Sector ETF

Dec 15 • Index Universe • Comment!
December's Game Plan for Biotech

Dec 1 • Justin M. Hall • 4 Comments
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
Biotech Stocks for a Possible Year-End Rally

Nov 18 • R. Scott Raynovich • 2 Comments
ETF Ideas for Obama's Healthcare and Energy Policies

Nov 15 • Tom Lydon • 2 Comments
Thursday Outlook: Creating a Liquidity Bubble

Nov 4 • David Fry • Comment!
Wednesday Outlook: Oversold Bounce Time?

Oct 27 • David Fry • Comment!
The San Francisco MoneyShow ETF Panel: Investor Favorites

Oct 21 • Ron Rowland • Comment!
Monday Options Update: TER, POT, IOC, QLGC, CAT, IBB

Oct 19 • Andrew Wilkinson • Comment!
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Tuesday Outlook: Yom Kippur Rally

Sep 28 • David Fry • Comment!
Grading ETF Risk: Why Tech, Biotech ETFs Are Half as Risky as Financial Cousins

Sep 24 • Gary Gordon • 1 Comment
Tuesday Outlook: Waiting for the Fed to Supply an Exit Strategy

Sep 21 • David Fry • Comment!
Friday Outlook: Can't Kill the Beast

Sep 17 • David Fry • Comment!
Pundits Are Wrong: Healthcare Reform Will Increase Profits

Sep 17 • Todd Campbell • 24 Comments
Biotech ETFs Lift Portfolios Higher than Broad-Based Healthcare ETFs

Sep 15 • Gary Gordon • Comment!
Hedge Fund Blue Ridge Concentrates on Apple

Sep 3 • Market Folly • 4 Comments
Pharma, Biotech ETFs Should Benefit from Swine Flu Vaccine, Healthcare Politics

Aug 27 • Gary Gordon • Comment!
Tuesday Outlook: Summer Doldrums

Aug 24 • David Fry • Comment!
Healthcare ETFs Headed for Life Support?

Aug 16 • Michael Johnston • 2 Comments
Global Markets in Review: Emerging Markets Showing First Signs of Retrenchment?

Aug 9 • Prieur du Plessis • 18 Comments
7 Reasons Biotech ETFs Could Succeed

Aug 6 • Tom Lydon • Comment!
Too Late to Board the Biotech Bandwagon?

Jul 28 • Sam Subramanian • 5 Comments
Biotech ETFs Surge Again on M&A News

Jul 24 • Michael Johnston • Comment!
Biotech ETFs Get Big Boost from HGSI

Jul 22 • Michael Johnston • 1 Comment
ETF Update: Good Prognosis for Health Stocks in a Bad Market?

Jul 6 • Jeff Miller • 4 Comments
Is IBB the Best Biotech ETF?

Jul 2 • Don Dion • 1 Comment
5 Best Diversifiers for Reducing Emerging Market Risk

Jul 1 • Gary Gordon • 1 Comment
Wednesday Outlook: Liquidity + BS = Positive Quarter

Jun 30 • David Fry • Comment!
Health Care Reform and Biotech ETFs: Will There Be Opportunities for Profit?

Jun 29 • Tom Lydon • 1 Comment
Playing Health Care Reform with Biotech ETFs IBB and XBI

Jun 18 • Invest With An Edge • 3 Comments
Five Smart Ways to Use Sector ETFs

Jun 18 • Sam Subramanian • Comment!
Biotech ETFs: A Better Way to Go

Jun 17 • Tom Lydon • 1 Comment
Can Obama’s Reform Proposals Reignite Biotech and Health Care ETFs?

Jun 16 • Tom Lydon • Comment!
Exploring Biotech ETFs

Jun 16 • Ron Rowland • Comment!
Where the Big Money Is Betting Big

May 15 • Andrew Mickey • 45 Comments
How Biotech ETFs Can Rise Above Challenges

May 12 • Tom Lydon • 1 Comment
Micromet: More Reasons for Optimism

May 11 • Ohad Hammer • 7 Comments
Stem Cell Index Surges in Past Week

May 11 • Mike Havrilla • 3 Comments

iShares Nasdaq Biotechnology (IBB)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers